Re:Death rates are declining for many common cancers in the ...
by jghn on Thursday July 08, 2021 @09:23PM
(#27779558)
Exactly. Insurance companies are very interested in Real World Data (RWD) around genomic based treatments. By using those data they can have a better sense of which patients would be likely to respond to which drugs, and steer treatment that way.
[ Parent
| on HN ]